Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 929 of 1,261
  1. WO 2012039887

    COMPOSITION ET MÉTHODE ACCÉLÉRANT LA CICATRISATION DES PLAIES

    BAUSCH & LOMB [US] · Granted Mar 29, 2012 · Expires Mar 24, 2032

    granted
  2. US 8143276

    4-thio substituted quinoline and naphthyridine compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  3. US 8143232

    Gene fusion targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  4. US 8143252

    Tetrahalogenated compounds useful as inhibitors of angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  5. US 8143226

    Tyrosine kinase receptor antagonists and methods of treatment for breast cancer

    The Regents of the University of California · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  6. US 8143214

    Protein-polymer conjugates

    PHARMAESSENTIA CORPORATION · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  7. US 8143257

    Substituted phenols as active agents inhibiting VEGF production

    PTC THERAPEUTICS, INC. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  8. US 8143277

    Method of using compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  9. US 8143218

    Treatment of skin, and wound repair, with thymosin beta 4

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  10. US 8142787

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  11. US 8143390

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  12. US 8143297

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  13. US 8143258

    Benzothiazole compounds useful for Raf inhibition

    Takeda Pharmaceutical Company Limited · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  14. US 8142809

    Compositions and methods to lower glycohemoglobin levels

    Regent of the Univ. of Minnesota · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  15. US 8143412

    Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

    The Board of Regents of the University of Texas System · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  16. US 8143445

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  17. US 8143279

    Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  18. US 8143295

    Compounds having activity in correcting mutant-CFTR processing and uses thereof

    The Regents of the University of California · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  19. US 8143308

    Synthesis of oligo/poly(catechins) and methods of use

    The United States of America as represented by the Secretary of the Army · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  20. US 8143298

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  21. US 8143378

    Polymer factor VIII moiety conjugates

    Nektar Therapeutics · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  22. US 8143418

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  23. FR 2964876

    COMPOSITION ANESTHESIQUE GAZEUSE A BASE DE XENON UTILISABLE PENDANT UNE ENDARTERIECTOMIE AVEC CLAMPAGE DE L'ARTERE CAROTIDE

    AIR LIQUIDE SANTE INT [FR] · Granted Mar 23, 2012 · Expires Mar 18, 2032

    granted
  24. US 8138345

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance, Inc. · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.